Cargando...

An ATRActive future for differentiation therapy in AML

The success of all-trans retinoic acid (ATRA) therapy in acute promeylocytic leukemia (APL) has spawned numerous attempts to translate the paradigm of differentiation therapy to non-APL acute myelocytic leukemia (AML). However, the results of clinical trials have been overall disappointing. In this...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Blood Rev
Main Authors: Johnson, Daniel E., Redner, Robert L.
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4494875/
https://ncbi.nlm.nih.gov/pubmed/25631637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.blre.2015.01.002
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!